HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 45, 2012, Pages 18541-18546

  Stolp, Bettina ^a,b   Imle, Andrea ^a   Coelho, FernandaMatos ^b   Hons, Miroslav ^b   Gorina, Roser ^b   Lyck, Ruth ^b   Stein, Jens V ^b   Fackler, Oliver T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

T lymphocyte homing; Two photon intravital microscopy

Indexed keywords

ACTIN; NEF PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL MOTILITY; CELL POLARITY; DIAPEDESIS; EX VIVO STUDY; EXTRAVASATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THREE DIMENSIONAL IMAGING;

ANIMALS; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; ENDOTHELIUM, VASCULAR; HIV-1; LYMPH NODES; MICE; MICE, INBRED C57BL; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POROSITY; STRESS, MECHANICAL; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VENULES;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 84868585862     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1204322109     Document Type: Article

References (45)

1. Laguette N, Brégnard C, Benichou S, Basmaciogullari S (2010) Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol Aspects Med 31(5):418-433.
2. Haller C, et al. (2006) The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J Biol Chem 281(28):19618-19630. (Pubitemid 44035465)
3. Rudolph JM, Eickel N, Haller C, Schindler M, Fackler OT (2009) Inhibition of T-cell receptor-induced actin remodeling and relocalization of Lck are evolutionarily conserved activities of lentiviral Nef proteins. J Virol 83(22):11528-11539.
4. Stolp B, Abraham L, Rudolph JM, Fackler OT (2010) Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling. J Virol 84(8):3935-3948.
5. Stolp B, et al. (2009) HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe 6(2):174-186.
6. Fackler OT, Luo W, Geyer M, Alberts AS, Peterlin BM (1999) Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol Cell 3(6):729-739. (Pubitemid 29323051)
7. Lu TC, et al. (2008) HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem 283(13):8173-8182.
8. Nobile C, et al. (2010) HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. J Virol 84(5):2282-2293.
9. Agopian K, Wei BL, Garcia JV, Gabuzda D (2006) A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J Virol 80(6):3050-3061. (Pubitemid 43346400)
10. Haller C, Tibroni N, Rudolph JM, Grosse R, Fackler OT (2011) Nef does not inhibit Factin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse. Eur J Cell Biol 90(11):913-921.
11. Schindler M, et al. (2007) Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue. J Virol 81(23):13005-13014. (Pubitemid 350156939)
12. Choe EY, Schoenberger ES, Groopman JE, Park IW (2002) HIV Nef inhibits T cell migration. J Biol Chem 277(48):46079-46084. (Pubitemid 35417595)
13. Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J (2004) HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol 2(1):E6.
14. Park IW, He JJ (2009) HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants. J Leukoc Biol 86(5):1171-1178.
15. Worbs T, Mempel TR, Bölter J, von Andrian UH, Förster R (2007) CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 204(3):489-495. (Pubitemid 46457073)
16. Boscacci RT, et al. (2010) Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood 116(6):915-925.
17. Bajénoff M, et al. (2007) Highways, byways and breadcrumbs: Directing lymphocyte traffic in the lymph node. Trends Immunol 28(8):346-352. (Pubitemid 47077926)
18. Stein JV, Nombela-Arrieta C (2005) Chemokine control of lymphocyte trafficking: A general overview. Immunology 116(1):1-12. (Pubitemid 41208347)
19. Sobocinski GP, et al. (2010) Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: Evidence supporting the reticular network as a pathway for lymphocyte migration. BMC Immunol 11:42.
20. Pouw NM, Westerlaken EJ, Willemsen RA, Debets R (2007) Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes. J Gene Med 9(7):561-570. (Pubitemid 47073988)
21. Pan X, et al. (2012) HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling. Blood 119(3):786-797.
22. Volinsky N, Gantman A, Yablonski D (2006) A Pak-and Pix-dependent branch of the SDF-1alpha signalling pathway mediates T cell chemotaxis across restrictive barriers. Biochem J 397(1):213-222. (Pubitemid 44032853)
23. Faroudi M, et al. (2010) Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood 116(25):5536-5547.
24. Steiner O, et al. (2010) Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J Immunol 185(8):4846-4855.
25. Shulman Z, et al. (2012) Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots. Nat Immunol 13(1):67-76.
26. Alon R, Shulman Z (2011) Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriers. Exp Cell Res 317(5):632-641.
27. Lämmermann T, et al. (2008) Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453(7191):51-55. (Pubitemid 351630331)
28. Soriano SF, et al. (2011) In vivo analysis of uropod function during physiological T cell trafficking. J Immunol 187(5):2356-2364.
29. Murooka TT, et al. (2012) HIV-infected T cells are migratory vehicles for viral dissemination. Nature 490(7419):283-287.
30. Mukerji J, Olivieri KC, Misra V, Agopian KA, Gabuzda D (2012) Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology 9:33.
31. Muller WA (2011) Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 6:323-344.
32. Cinamon G, Shinder V, Alon R (2001) Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2(6):515-522. (Pubitemid 33705853)
33. Gérard A, van der Kammen RA, Janssen H, Ellenbroek SI, Collard JG (2009) The Rac activator Tiam1 controls efficient T-cell trafficking and route of transendothelial migration. Blood 113(24):6138-6147.
34. Heasman SJ, Carlin LM, Cox S, Ng T, Ridley AJ (2010) Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migration. J Cell Biol 190(4):553-563.
35. Nombela-Arrieta C, et al. (2007) A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J Exp Med 204(3):497-510.
36. Shulman Z, et al. (2006) DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration. Blood 108(7):2150-2158. (Pubitemid 44497494)
37. Sánchez-Madrid F, del Pozo MA (1999) Leukocyte polarization in cell migration and immune interactions. EMBO J 18(3):501-511. (Pubitemid 29057235)
38. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF (2010) The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol 10(1):11-23.
39. Moir S, Fauci AS (2009) B cells in HIV infection and disease. Nat Rev Immunol 9(4):235-245.
40. Muratori C, et al. (2009) Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 6(3):218-230.
41. Stumptner-Cuvelette P, et al. (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 98(21):12144-12149. (Pubitemid 32959841)
42. Swingler S, et al. (2008) Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 4(1):63-76. (Pubitemid 351958115)
43. Xu W, et al. (2009) HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 10 (9):1008-1017.
44. Fujii H, et al. (2011) HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice. Int Immunol 23(7):433-441.
45. Sugimoto C, et al. (2003) nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes. J Virol 77(7):4169-4180. (Pubitemid 36350956)